Literature DB >> 21930754

Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

Lauren J McAllister1, Abiodun D Ogunniyi, Uwe H Stroeher, Amanda J Leach, James C Paton.   

Abstract

The capsular serotype has long been associated with the virulence of Streptococcus pneumoniae. Here we present an in-depth study of phenotypic and genetic differences between serotype 3 and serogroup 11 S. pneumoniae clinical isolates from both the general and indigenous populations of Australia. Both serotypes/groups included clonally unrelated strains with differences in well-known polymorphic virulence genes, such as nanA and pspA, as demonstrated by multilocus sequence typing and Western blot analysis. Nonetheless, the serotype 3 strains were consistently and significantly more virulent in mice than the serogroup 11 strains. Despite extensive genomic analysis, noncapsular genes common to one serotype/group but not the other were not identified. Nevertheless, following the conversion of a serotype 11A isolate to serotype 3 and subsequent analysis in an intranasal infection model, it was evident that both capsular and noncapsular factors determine the virulence phenotype in mice. However, it appears that these noncapsular factors vary from strain to strain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930754      PMCID: PMC3232656          DOI: 10.1128/IAI.05663-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

1.  Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenome.

Authors:  N Luisa Hiller; Benjamin Janto; Justin S Hogg; Robert Boissy; Susan Yu; Evan Powell; Randy Keefe; Nathan E Ehrlich; Kai Shen; Jay Hayes; Karen Barbadora; William Klimke; Dmitry Dernovoy; Tatiana Tatusova; Julian Parkhill; Stephen D Bentley; J Christopher Post; Garth D Ehrlich; Fen Z Hu
Journal:  J Bacteriol       Date:  2007-08-03       Impact factor: 3.490

2.  Genomic diversity between strains of the same serotype and multilocus sequence type among pneumococcal clinical isolates.

Authors:  Nuno A Silva; Jackie McCluskey; Johanna M C Jefferies; Jason Hinds; Andrew Smith; Stuart C Clarke; Tim J Mitchell; Gavin K Paterson
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

3.  Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland.

Authors:  William P Hanage; Tarja H Kaijalainen; Ritva K Syrjänen; Kari Auranen; Maija Leinonen; P Helena Mäkelä; Brian G Spratt
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.

Authors:  S K Hollingshead; R Becker; D E Briles
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.

Authors:  H Tettelin; K E Nelson; I T Paulsen; J A Eisen; T D Read; S Peterson; J Heidelberg; R T DeBoy; D H Haft; R J Dodson; A S Durkin; M Gwinn; J F Kolonay; W C Nelson; J D Peterson; L A Umayam; O White; S L Salzberg; M R Lewis; D Radune; E Holtzapple; H Khouri; A M Wolf; T R Utterback; C L Hansen; L A McDonald; T V Feldblyum; S Angiuoli; T Dickinson; E K Hickey; I E Holt; B J Loftus; F Yang; H O Smith; J C Venter; B A Dougherty; D A Morrison; S K Hollingshead; C M Fraser
Journal:  Science       Date:  2001-07-20       Impact factor: 47.728

6.  Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae.

Authors:  C Blomberg; J Dagerhamn; S Dahlberg; S Browall; J Fernebro; B Albiger; E Morfeldt; S Normark; B Henriques-Normark
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

7.  The recA gene of Streptococcus pneumoniae is part of a competence-induced operon and controls lysogenic induction.

Authors:  B Martin; P García; M P Castanié; J P Claverys
Journal:  Mol Microbiol       Date:  1995-01       Impact factor: 3.501

8.  Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey.

Authors:  Peter S Morris; Amanda J Leach; Peter Silberberg; Gabrielle Mellon; Cate Wilson; Elizabeth Hamilton; Jemima Beissbarth
Journal:  BMC Pediatr       Date:  2005-07-20       Impact factor: 2.125

9.  Regions of Diversity 8, 9 and 13 contribute to Streptococcus pneumoniae virulence.

Authors:  Addie Embry; Ernesto Hinojosa; Carlos J Orihuela
Journal:  BMC Microbiol       Date:  2007-08-27       Impact factor: 3.605

10.  Characterization and modeling of the Haemophilus influenzae core and supragenomes based on the complete genomic sequences of Rd and 12 clinical nontypeable strains.

Authors:  Justin S Hogg; Fen Z Hu; Benjamin Janto; Robert Boissy; Jay Hayes; Randy Keefe; J Christopher Post; Garth D Ehrlich
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  16 in total

1.  Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis.

Authors:  Abiodun D Ogunniyi; Layla K Mahdi; Claudia Trappetti; Nadine Verhoeven; Daphne Mermans; Mark B Van der Hoek; Charles D Plumptre; James C Paton
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

2.  Surface association of Pht proteins of Streptococcus pneumoniae.

Authors:  Charles D Plumptre; Abiodun D Ogunniyi; James C Paton
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

3.  The Variable Region of Pneumococcal Pathogenicity Island 1 Is Responsible for Unusually High Virulence of a Serotype 1 Isolate.

Authors:  Richard M Harvey; Claudia Trappetti; Layla K Mahdi; Hui Wang; Lauren J McAllister; Alexandra Scalvini; Adrienne W Paton; James C Paton
Journal:  Infect Immun       Date:  2016-01-11       Impact factor: 3.441

4.  The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010-2019.

Authors:  Eiman Mokaddas; Shabeera Syed; M John Albert
Journal:  Hum Vaccin Immunother       Date:  2021-08-26       Impact factor: 4.526

5.  Synthesis and Application of Rare Deoxy Amino l-Sugar Analogues to Probe Glycans in Pathogenic Bacteria.

Authors:  Phuong Luong; Antara Ghosh; Karen D Moulton; Suvarn S Kulkarni; Danielle H Dube
Journal:  ACS Infect Dis       Date:  2022-03-18       Impact factor: 5.578

6.  Site of isolation determines biofilm formation and virulence phenotypes of Streptococcus pneumoniae serotype 3 clinical isolates.

Authors:  Claudia Trappetti; Erika van der Maten; Zarina Amin; Adam J Potter; Austen Y Chen; Paula M van Mourik; Andrew J Lawrence; Adrienne W Paton; James C Paton
Journal:  Infect Immun       Date:  2012-12-03       Impact factor: 3.441

7.  Isolation site influences virulence phenotype of serotype 14 Streptococcus pneumoniae strains belonging to multilocus sequence type 15.

Authors:  Zarina Amin; Richard M Harvey; Hui Wang; Catherine E Hughes; Adrienne W Paton; James C Paton; Claudia Trappetti
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

8.  Contribution of a genomic accessory region encoding a putative cellobiose phosphotransferase system to virulence of Streptococcus pneumoniae.

Authors:  Lauren J McAllister; Abiodun D Ogunniyi; Uwe H Stroeher; James C Paton
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

9.  Streptococcus pneumoniae Strains Isolated From a Single Pediatric Patient Display Distinct Phenotypes.

Authors:  Hannah N Agnew; Erin B Brazel; Alexandra Tikhomirova; Mark van der Linden; Kimberley T McLean; James C Paton; Claudia Trappetti
Journal:  Front Cell Infect Microbiol       Date:  2022-03-31       Impact factor: 6.073

10.  Streptococcus pneumoniae serotype 3 genotypes in invasive isolates from Colombia.

Authors:  Zonia Katerin Alarcón; Carolina Duarte; Olga Sanabria; Jaime Moreno
Journal:  Biomedica       Date:  2021-06-29       Impact factor: 0.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.